Related Experiment Videos
[Non-occlusive mesenteric infarction following cardiovascular surgery]
O Kawaguchi1, K Kumon, T Hirata
1Department of Cardiovascular Surgery, National Cardiovascular Center Hospital, Osaka, Japan.
Summary
Non-occlusive mesenteric infarction, often occurring after cardiovascular surgery in patients with severe cardiac failure, presents with subtle symptoms and a grave 100% mortality rate. Early surgical intervention may improve outcomes.
Area of Science:
- Gastroenterology
- Cardiovascular Surgery
- Critical Care Medicine
Context:
- Intestinal infarction is frequently linked to mesenteric vascular occlusion.
- However, a subset of patients presents with non-occlusive mesenteric infarction (NOMI) without identifiable vascular lesions.
- NOMI is often a terminal event in critically ill patients, particularly those with severe cardiac failure post-cardiovascular surgery.
Purpose:
- To investigate the clinical characteristics, diagnosis, and outcomes of patients with non-occlusive mesenteric infarction following cardiovascular surgery.
- To evaluate the efficacy of conservative versus aggressive management strategies for NOMI in this patient population.
Summary:
- A study of 24 patients with mesenteric infarction post-cardiovascular surgery identified 15 with organic vascular occlusion and 9 with NOMI.
- NOMI patients exhibited severe postoperative cardiac failure, non-specific symptoms (abdominal fullness, diarrhea), and elevated liver enzymes (GOT, LDH, CPK) with a GOT/GPT discrepancy.
- Diagnosis was challenging due to subtle clinical signs; all NOMI patients died (100% mortality), with conservative management accelerating decline and preventing recovery from cardiac failure.
Impact:
- Non-occlusive mesenteric infarction in post-cardiovascular surgery patients with severe cardiac failure carries a uniformly fatal prognosis with current conservative management.
- The subtle presentation and critical illness severity complicate diagnosis and treatment.
- Aggressive surgical intervention for acute mesenteric ischemia in this high-risk group may represent a potential avenue for improved survival, warranting further investigation.